CureVac

+$1.16 (+2.91%) Today
$0.00 (0.00%) As of 8:37 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.

CEO
Franz-Werner Haas
Employees
554
Headquarters
Tubingen, Baden Wuerttemberg
Founded
2000

CVAC Key Statistics

Market Cap
7.63B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.10M
High Today
$41.50
Low Today
$39.79
Open Price
$40.21
Volume
826.60K
52 Week High
$151.80
52 Week Low
$37.54

CVAC Earnings

-$65.03
-$43.35
-$21.68
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Jan 29, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure